Intragastric Balloons Market Insights 2025-2034: Growth Forecast and Strategic Priorities

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Intragastric Balloons Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The expansion of the intragastric balloons market has been considerable in recent times, with an increase set to surge from $19.89 billion in 2024 to $22.21 billion in 2025, maintaining a compound annual growth rate (CAGR) of 11.7%. Factors contributing to the growth during the historical period include increasing obesity rates, escalating healthcare costs, clinical validations and FDA approvals, publicity endeavors, enhanced balloon design, and a surge in medical tourism.

Intragastric Balloons Market Size Forecast: What's the Projected Valuation by 2029?
Anticipated to experience swift expansion in the coming years, the intragastric balloons market size is projected to reach $34.23 billion in 2029, boasting a compound annual growth rate (CAGR) of 11.4%. This proliferation during the forecast period is majorly prompted by factors such as celebrity endorsements, complications related to obesity, the growth of emerging markets, the rising number of endoscopic procedures, an older population, and bespoke treatment plans. Key trends in the corresponding forecast span include technological breakthroughs, publicity via social media, synergy with digital health services, the advent of artificial intelligence, virtual patient consultations and reinforced patient education initiatives.

View the full report here:
https://www.thebusinessresearchcompany.com/report/intragastric-balloons-global-market-report

What Are the Drivers Transforming the Intragastric Balloons Market?
The rise in obesity rates is predicted to fuel the expansion of the intragastric balloon market. Obesity rates pertain to the ratio or percentage of a populace classified as obese based on their body mass index (BMI), typically defined as a BMI of 30 or above. The escalating obesity rates can be attributed to factors such as dietary preferences, inactive lifestyle, economic considerations, promotional campaigns, genetics and biology, psychological and emotion-related causes, and urban development. Intragastric balloons are used by obese people as a non-invasive method to facilitate weight loss by taking up space in the stomach, triggering a sense of satiety, and curbing food consumption. For example, the World Obesity Atlas 2022, published by the World Obesity Federation, a non-profit organisation based in the UK, reported in March 2023 that the global financial repercussion of overweight and obesity could reach $4.32 trillion annually by 2035 if the current prevention and treatment strategies persist. By that point, more than half of the global population (51% or over 4 billion people) may be impacted by overweight or obesity, and roughly 2 billion people-one in every four-are anticipated to face obesity if the present trend continues. Consequently, the rising obesity statistics are contributing to the expansion of the intragastric balloon market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15835&type=smp

What Long-Term Trends Will Define the Future of the Intragastric Balloons Market?
Leading companies in the intragastric balloon market are directing their efforts towards innovating advanced medical weight-loss devices such as ingestible gastric balloons. These advancements are meant to improve patient comfort, simplicity of use, and availability. Ingestible gastric balloons are non-invasive tools that aid in shedding weight by temporarily filling up a part of the stomach, helping to curb food intake by inducing a sense of satiety. For instance, in September 2022, Allurion Technologies Inc., a medical device firm based in the USA, introduced a swallowable gastric balloon capsule to the Indian market. This represents the first of its kind in the world as a non-surgical swallowable gastric balloon, eliminating the need for endoscopy or anesthesia during placement or removal. The Allurion gastric balloon capsule brings forth a secure, non-invasive, and effective weight loss solution, enabling people to achieve substantial weight loss and instil healthier lifestyle habits for enduring success.

Which Segments in the Intragastric Balloons Market Offer the Most Profit Potential?
The intragastric balloons market covered in this report is segmented -

1) By Type: Single, Dual, Triple Intragastric Balloons
2) By Filling Material: Saline Filled, Gas Filled
3) By Distribution Channel: Online Pharmacies, Retail Pharmacies, Hospital Pharmacies
4) By Application Areas: Obesity, Diabetes, Diet Control, Weight-loss, Pre-operative Weight Reduction, Other Applications
5) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users

Subsegments:
1) By Single Intragastric Balloon: Silicone-Based Single Balloon, Non-silicone-Based Single Balloon
2) By Dual Intragastric Balloon: Silicone-Based Dual Balloon, Non-silicone-Based Dual Balloon
3) By Triple Intragastric Balloon: Silicone-Based Triple Balloon, Non-silicone-Based Triple Balloon

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15835&type=smp

Which Firms Dominate the Intragastric Balloons Market by Market Share and Revenue in 2025?
Major companies operating in the intragastric balloons market are Medtronic plc, Mayo Clinic, Boston Scientific Corporation, Cleveland Clinic, Mediclinic Group, Spire Healthcare Group plc, Micro-Tech (Nanjing) Co., Ltd., American Hospital Dubai LLC, Silimed GmbH, Apollo Endosurgery Inc., Allurion Technologies Inc., MedicalExpo, ReShape Lifesciences Inc., Districlass Medical SA, Healthware Private Limited, Spatz Medical, Helioscopie SA, Bariatric Solutions International GmbH, HexaHealth Care Pvt. Ltd., USGI Medical Inc., Inamed Health, Medsil, Obalon Therapeutics Inc., Endalis, Lexel SRL

Which Regions Offer the Highest Growth Potential in the Intragastric Balloons Market?
North America was the largest region in the intragastric balloons market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intragastric balloons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15835

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.